Skip to content

Oral Supplementation With AM3, Hesperidin and Spermidine Supplementation on Immunity Response and Biological Age.

A Randomized Controlled Trial of Oral Suplementation With AM3, Hesperidin and Spermidine on Immunity Response and Biological Age in Healthy Volunteers.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06249620
Enrollment
41
Registered
2024-02-08
Start date
2022-04-19
Completion date
2022-10-01
Last updated
2024-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

AM3, Biological age, Inmunology clock, Spermidine, Hesperidin

Brief summary

The goal of this interventional study is to know the immune status of healthy participants and to obtain their biological age before and after two months of ingesting a dietary supplement. These individuals are compared with others who will be given a product of similar appearance, but without containing active components, being the constituents of the placebo group. The study has a duration of 8 weeks, with 2 interventional visits (complete blood samples will be collected) at baseline and at 8 weeks. In order to be included in the trial, the patient must read the Patient Information Sheet and sign the informed consent form. The dosage regimen is two capsules per day in a single dose.

Detailed description

Forty consenting volunteers will be included in this prospective, randomized, double-blind study and will be randomized by a statistician independent of the research team. The study consists of two milestones, in which different parameters are evaluated to finally reach the main goal, to measure their immune status and their biological age after taking the supplement (whose active ingredients include AM3, polyamines and flavonoids): \- Complete blood samples are collected from participants at milestone 1. To determine immune functions; neutrophils, lymphocytes and NK cells are measured. The adherence and chemotaxis capacity of neutrophils and lymphocytes is determined, as well as neutrophil phagocytosis and lymphocyte proliferation. In addition, the release of pro-inflammatory and anti-inflammatory cytokines is assessed. In parallel, each participant will be given a survey to assess their perception of stress, which they will have to complete before and after 2 months of ingestion of the product (experimental and placebo). \- In milestone 2, oxidative and inflammatory stress parameters are analyzed. Regarding oxidative stress: catalase activity, glutathione reductase activity and reduced glutathione concentration are measured. In terms of inflammatory stress: concentrations of both proinflammatory and anti-inflammatory cytokines released are measured.

Interventions

DIETARY_SUPPLEMENTInmunoferon

The dosage regimen is two capsules (with the active ingredients) per day in a single dose.The study lasted 8 weeks, with 2 interventional visits at baseline and at 8 weeks. Blood samples are collected twice: once on day 0 of the study and again at the final visit.

DIETARY_SUPPLEMENTPlacebo

The dosage regimen is two capsules (with inert ingredients) per day in a single dose.The study lasted 8 weeks, with 2 interventional visits at baseline and at 8 weeks. Blood samples are collected twice: once on day 0 of the study and again at the final visit.

Sponsors

Industrial Farmacéutica Cantabria, S.A.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
29 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy volunteers who give their consent for the study will be included after having read and understood the information provided in the informed consent document * Between 29-65 years old * Residents in the Community of Madrid

Exclusion criteria

* Volunteers with no allergies or intolerances to the product * Patologies * Excessive alcohol consumption * Pregnant women * Antioxidants intake from supplements

Design outcomes

Primary

MeasureTime frameDescription
Change in Biological AgeBaseline and Week 8The Biological Age will be determined at baseline and week 8, by using the mathematical model 'Immunity Clock', based on the the natural killer activity, Lymphoproliferation and phagocytosis, and neutrophils and lymphocyts chemotaxis

Secondary

MeasureTime frameDescription
Change in Glutathione peroxidase levelsBaseline and week 8To determine glutathione peroxidase levels at baseline and week 8 to asseess oxidative stress.
Change in Glutathione reductase levelsBaseline and week 8To determine glutathione reductase levels at baseline and week 8 to assess oxidative stress.
Change in reduced/oxized glutathione concentrations (GSH/GSSG)Baseline and week 8To determine educed/oxized glutathione concentrations at baseline and week 8 to asseess oxidative stress.
Change in inflammatory and anti-inflammatory cytokines levelsBaseline and week 8To determine levels of both inflammatory and anti-inflammatory cytokines at baseline and week 8 for evaluation of inflammatory stress.
Change in Malondialdehyde concentrationsBaseline and week 8To determine concentration levels of malondialdehyde at baseline and at week 8 to evaluate peroxidative damage.
Change in catalase activity with the use of a spectrophotometerBaseline and week 8Measuring catalase activity with the use of a spectrophotometer will be used to assess oxidative stress at baseline and week 8 of treatment.
Change in lymphocyte levelsBaseline and week 8To determine lymphocite levels at baseline and week 8 to analyze the immunological functions.
Change in cytotoxic activity of natural killerBaseline and week 8The cytotoxic activity of NK cells was assessed by colorimetry of target cell lysis at baseline and week 8 of tretment to analyze the immunological functions.
Change in chemotaxis indexBaseline and week 8To analyze the immunological functions, the chemotaxis index was calculated at baseline and week 8 to assess the migration capacity of neutrophils and lymphocytes .
Change in lymphoproliferation levelsBaseline and week 8To analyze the immunological functions, lymphoproliferation capacity by neutrophils was measured at baseline and week 8.
Change in phagocytosis activityBaseline and week 8To analyze the immunological functions, phagocytosis activity by the neutrophils will also be determined at baseline and week 8 of treatment. Phagocytosis is a critical biological activity through which the host can protect itself from infectious and non-infectious environmental particles and remove unwanted host cells in order to maintain tissue homeostasis.
Change in neutrophil levelsBaseline and week 8To determine neutrophil levels at baseline and week 8 to analyze the immunological functions.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026